Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations
Numerous prescription drugs’ labeling contains pharmacogenomic (PGx) information to aid health providers and patients in the safe and effective use of drugs. However, clinical studies for such PGx biomarkers and related drug doses are generally not conducted in diverse ethnic populations. Thus, it i...
Main Authors: | Dan Li, April Hui Xie, Zhichao Liu, Dongying Li, Baitang Ning, Shraddha Thakkar, Weida Tong, Joshua Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/11/1021 |
Similar Items
-
Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1
by: Dan Li, et al.
Published: (2024-12-01) -
A pharmacogenomic method for individualized prediction of drug sensitivity
by: Adam L Cohen, et al.
Published: (2011-07-01) -
Pharmacogenomics in drug discovery and development /
by: Yan, Qing, 1971-
Published: (2008) -
Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
by: Mo-Yun Li, et al.
Published: (2022-10-01) -
Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023-03-01)